231 related articles for article (PubMed ID: 24709297)
1. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
Novotny D; Vaverkova H; Karasek D; Malina P
Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
[TBL] [Abstract][Full Text] [Related]
2. The influence of apolipoprotein A5 T-1131C and apolipoprotein E common genetic variants on the levels of hemostatic markers in dyslipidemic patients.
Novotny D; Karasek D; Vaverkova H; Slavik L
Clin Chim Acta; 2014 Sep; 436():11-7. PubMed ID: 24815086
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
Zaki M; Amr K
Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
[TBL] [Abstract][Full Text] [Related]
4. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
5. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
[TBL] [Abstract][Full Text] [Related]
7. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
8. The polymorphism -1131T>C in apolipoprotein A5 gene is associated with dyslipidemia in Brazilian subjects.
Ferreira CN; Carvalho MG; Fernandes AP; Santos IR; Rodrigues KF; Lana AM; Almeida CR; Loures-Vale AA; Gomes KB; Sousa MO
Gene; 2013 Mar; 516(1):171-5. PubMed ID: 23266809
[TBL] [Abstract][Full Text] [Related]
9. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
[TBL] [Abstract][Full Text] [Related]
10. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome.
Kisfali P; Mohás M; Maász A; Polgár N; Hadarits F; Markó L; Brasnyó P; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Rinfel J; Wittmann I; Melegh B
Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):505-11. PubMed ID: 19692219
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke.
Havasi V; Szolnoki Z; Talián G; Bene J; Komlósi K; Maász A; Somogyvári F; Kondacs A; Szabó M; Fodor L; Bodor A; Melegh B
J Mol Neurosci; 2006; 29(2):177-83. PubMed ID: 16954607
[TBL] [Abstract][Full Text] [Related]
12. Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects.
Li YY; Wu XY; Xu J; Qian Y; Zhou CW; Wang B
Mol Biol Rep; 2013 Feb; 40(2):1997-2014. PubMed ID: 23129316
[TBL] [Abstract][Full Text] [Related]
13. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
[TBL] [Abstract][Full Text] [Related]
14. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
17. Diversity of apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of metabolic syndrome among hypertensive patients.
Teixeira AA; Marrocos MS; Quinto BM; Dalboni MA; Rodrigues CJ; Carmona Sde M; Kuniyoshi M; Batista MC
Lipids Health Dis; 2014 Nov; 13():174. PubMed ID: 25413697
[TBL] [Abstract][Full Text] [Related]
18. Association of apolipoprotein A5 gene polymorphisms and serum lipid levels.
Li YY; Yin RX; Lai CQ; Li M; Long XJ; Li KL; Liu WY; Zhang L; Wu JZ
Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):947-56. PubMed ID: 20708914
[TBL] [Abstract][Full Text] [Related]
19. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.
Brito DD; Fernandes AP; Gomes KB; Coelho FF; Cruz NG; Sabino AP; Cardoso JE; Figueiredo-Filho PP; Diamante R; Norton CR; Sousa MO
Mol Biol Rep; 2011 Oct; 38(7):4381-8. PubMed ID: 21132386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
